| abstract |
Described herein are anti-CD20 antibodies, anti-CD37 antibodies, and mixtures thereof, as well as nucleic acids encoding these antibodies and mixtures, vectors comprising these nucleic acids, and host cells containing these nucleic acids and/or vectors. Further described herein are methods for making and using these antibodies, mixtures of antibodies, nucleic acids, and vectors. Uses include therapeutic uses to treat a variety of conditions including cancers. |